HF Acquisition Co LLC, DBA HealthFirst drugs

45 results

  • 0.9% sodium chloride (0.9% sodium chloride)

    (0.9% SODIUM CHLORIDE)
    HF Acquisition Co LLC, DBA HealthFirst
    Usage: Sodium chloride intravenous solutions are indicated for parenteral replenishment of fluids and sodium chloride based on the patient's clinical needs.

  • 0.9% sodium chloride (0.9% sodium chloride)

    (0.9% SODIUM CHLORIDE)
    HF Acquisition Co LLC, DBA HealthFirst
    Usage: Intravenous sodium chloride solutions are indicated for parenteral replenishment of fluids and sodium chloride, tailored to the patient's clinical condition.

  • Adrenalin (epinephrine) (adrenalin (epinephrine))

    (ADRENALIN (EPINEPHRINE))
    HF Acquisition Co LLC, DBA HealthFirst
    Usage: Adrenalin® is indicated for emergency treatment of Type I allergic reactions, including anaphylaxis triggered by various allergens such as insect stings, foods, and medications. It addresses symptoms like hypotension, airway swelling, and bronchospasm. Available in 1 mL and 30 mL vials for intramuscular or subcutaneous use.

  • Albuterol sulfate (albuterol sulfate)

    (ALBUTEROL SULFATE)
    HF Acquisition Co LLC, DBA HealthFirst
    Usage: Albuterol sulfate inhalation solution is indicated for relieving bronchospasm in patients aged 2 years and older with reversible obstructive airway disease and during acute bronchospasm attacks.

  • Amiodarone hydrochloride (amiodarone hydrochloride)

    (AMIODARONE HYDROCHLORIDE)
    HF Acquisition Co LLC, DBA HealthFirst
    Usage: Amiodarone hydrochloride injection is indicated for the initiation and prophylaxis of frequently recurring ventricular fibrillation and unstable ventricular tachycardia in patients refractory to other treatments. It is also suitable for patients who require oral amiodarone but cannot take oral medication. Treatment duration may vary based on patient stability.

  • Auvi-q (auvi-q)

    (AUVI-Q)
    HF Acquisition Co LLC, DBA HealthFirst
    Usage: AUVI-Q® is indicated for the emergency treatment of Type I allergic reactions, including anaphylaxis from stinging and biting insects, foods, drugs, allergen immunotherapy, and other allergens. It is intended for immediate self-administration in individuals at increased risk for anaphylaxis and is not a substitute for medical care.

  • Auvi-q (auvi-q)

    (AUVI-Q)
    HF Acquisition Co LLC, DBA HealthFirst
    Usage: AUVI-Q® is indicated for the emergency treatment of Type I allergic reactions, including anaphylaxis from stinging/biting insects, foods, drugs, and other allergens. It is intended for immediate self-administration in patients at increased risk for anaphylaxis and is not a replacement for medical care.

  • Auvi-q (auvi-q)

    (AUVI-Q)
    HF Acquisition Co LLC, DBA HealthFirst
    Usage: AUVI-Q® is indicated for the emergency treatment of Type I allergic reactions, including anaphylaxis from various allergens (e.g., stinging and biting insects, foods, drugs). It is for patients at increased risk for anaphylaxis and is intended for immediate self-administration, not as a substitute for medical care.

  • Calcium gluconate (calcium gluconate)

    (CALCIUM GLUCONATE)
    HF Acquisition Co LLC, DBA HealthFirst
    Usage: Calcium Gluconate Injection is indicated for the treatment of acute symptomatic hypocalcemia in pediatric and adult patients. Its safety for long-term use has not been established.